BHWM
XBI icon

Bay Harbor Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bay Harbor Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4
Closed – – 434
2019
Q1 		$0 Hold
4
– – ﹤0.01% 437
2018
Q4 		$0 Buy
+4
New +$322 ﹤0.01% 409

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bay Harbor Wealth Management's XBI Position: Q2 2019 in Review

Bay Harbor Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 4 shares.

Bay Harbor Wealth Management first reported a position in XBI in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

  • Bay Harbor Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
  • Bay Harbor Wealth Management sold 4 State Street SPDR S&P Biotech ETF shares in Q2 2019.
  • Bay Harbor Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 2 quarters.
  • Bay Harbor Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $0 in Q1 2019.
  • 424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2019, filed 18 Jul 2019.